Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
Details for Australian Patent Application No. 2004257261 (hide)
International Classifications
Event Publications
12 January 2006 PCT application entered the National Phase
PCT publication WO2005/007647 Priority application(s): WO2005/007647
5 November 2009 Application Accepted
Published as AU-B-2004257261
4 March 2010 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 01 Feb 2010. Address for service in Australia - FB Rice & Co Level 23 44 Market Street Sydney NSW 2000
13 May 2010 Standard Patent Sealed
13 May 2010 Corrigenda
Applications Accepted - Name Index Under the name Arena Pharmaceuticals Inc., Application No. 2004257261, under INID (71) correct the applicant name to Arena Pharmaceuticals, Inc.
22 July 2010 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 01 Feb 2010
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser